MOATAZ YOUSEF HAGGAG

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry EAST PATCHOGUE, NY NPI 1508966565

General Payments — all program years on this page

$3,474.24

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 174
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $205.65 across 9 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $205.659

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ITI, Inc. $67.873
Neurocrine BioSciences, Inc. $64.143
Vanda Pharmaceuticals Inc. $45.672
E.R. Squibb & Sons, L.L.C. $27.971

By program year

Program yearAmountRecords
2018 $710.2739
2019 $792.5343
2020 $730.9033
2021 $627.1032
2022 $345.6715
2023 $62.123
2024 $205.659

Records — PY2024 (9)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1101862807 E.R. Squibb & Sons, L.L.C. $27.97 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133905241 Vanda Pharmaceuticals Inc. $24.17 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133905243 Vanda Pharmaceuticals Inc. $21.50 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143237593 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.97 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143237597 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.81 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143237601 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $31.09 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150825286 Neurocrine Biosciences, Inc. $30.40 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150866356 Neurocrine Biosciences, Inc. $17.75 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150872248 Neurocrine Biosciences, Inc. $15.99 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.